In this blog post we want to tell you a bit about one of the very first clinical trials we recruited for as we were getting started with Lindus Health earlier this year. We really enjoyed working with the team at DnaNudge and think it’s a great example of how Lindus Health can turbocharge recruitment!
Let’s start with some background and the recruitment challenge they were up against.
DnaNudge’s mission is to allow you to use your own DNA to inform your everyday choices, particularly around food and diet. They make health personal.
Their trial, ASPIRE-DNA, is being run in partnership with Imperial College London (source). The trial is investigating the effectiveness of a DNA-based diet on reducing the risk of developing type 2 diabetes in people who have pre-diabetes (source).
The primary objective, to see if there are any changes in glucose regulation (a primary indicator of diabetes risk) between the control and intervention groups.
Due to the Covid-19 pandemic pausing in-person research, trial enrolment was up to only ~50% of the target with just a couple of months to go until the completion date set for December 2021.
Standard recruitment channels had been exhausted. The team had worked with the local trials units, GPs and even developed a novel partnership with Waitrose.
With a trial duration of 26 weeks, the sponsors were keen to get people enrolled as soon as possible!
There is no “one size fits all” for trial recruitment. Each trial must be tailored to the patients each study is looking to enrol. Using a patient-centric recruitment approach is paramount but the channels that can or should be used will vary trial-to-trial. Using the right combination of recruitment channels will almost certainly turn out better recruitment results!
Best practices for advancing clinical research in the community
Hear from Chris Williams, a friend of Lindus Health and founder of Tiggo Care - a community care business supporting vulnerable adults in London - about best practices for conducting clinical research in the community.
Discussing DTx payor reimbursement and adoption with Mike Pace (PalmHealthCo and ex-Pear Tx)
Mike Pace stops by our virtual fireplace to share tips on how to achieve payor reimbursement for DTx products and encourage adoption among clinicians in the most attractive international markets.
Why I Joined Lindus Health - Emma Ogburn PhD, VP Clinical Operations
To work on innovative trials and accelerate access to treatments. To tackle disparities in research accessibility. To use technology to accelerate studies and work with a motivated team. Hear more from our VP of Clinical Operations, Emma Ogburn PhD, on why she joined Lindus Health.